title: Why do subjects on clinical trials discontinue therapy? Do we really know?
authors: Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Electronic address: brunom@stanford.edu.
authors: Bruno C
authors: BC
authors: Medeiros
authors: Haematology Research Centre, Division of Experimental Medicine, Department of Medicine, Imperial College London, London, SW7 2AZ, UK.
authors: Robert Peter
authors: RP
authors: Gale
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods / Q000706:statistics & numerical data*; D004358:Drug Therapy / Q000379:methods / Q000706:statistics & numerical data*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000209:etiology*; D006801:Humans; D017063:Outcome Assessment, Health Care / Q000379:methods / Q000706:statistics & numerical data; D035842:Research Subjects / Q000706:statistics & numerical data*; D016312:Treatment Refusal / Q000706:statistics & numerical data*
keywords: Attributions; Clinical trials